Literature DB >> 6647769

Cellular glutathione depletion by diethyl maleate or buthionine sulfoximine: no effect of glutathione depletion on the oxygen enhancement ratio.

J B Mitchell, A Russo, J E Biaglow, S McPherson.   

Abstract

The hypoxic and euoxic radiation response for Chinese hamster lung and A549 human lung carcinoma cells was obtained under conditions where their nonprotein thiols, consisting primarily of glutathione (GSH), were depleted by different mechanisms. The GSH conjugating reagent diethylmaleate (DEM) was compared to DL-buthionine-S,R-sulfoximine (BSO), an inhibitor of glutathionine biosynthesis. Each reagent depleted cellular GSH to less than 5% of control values. A 2-hr exposure to 0.5 mM DEM or a 4- or 24-hr exposure to BSO at 10 or 1 mM, respectively, depleted cellular GSH to less than 5% of control values. Both agents sensitized cells irradiated under air or hypoxic conditions. When GSH levels are lowered to less than 5% by both agents, hypoxic DEM-treated cells exhibited slightly greater X-ray sensitization than hypoxic BSO-treated cells. The D0's for hypoxic survival curves were as follows: control, 4.87 Gy; DEM, 3.22 Gy; and BSO, 4.30 Gy for the V79 cells and 5.00 Gy versus 4.02 Gy for BSO-treated A549 cells. The D0's for aerobic V79 cells were 1.70 Gy versus 1.13 Gy, DEM, and 1.43 Gy for BSO-treated cells. The D0's for the aerobic A549 were 1.70 and 1.20 for BSO-treated cells. The aerobic and anoxic sensitization of the cells results in the OER's of 2.8 and 3.0 for the DEM- and BSO-treated cells compared to 2.9 for the V79 control A549. BSO-treated cells showed an OER of 3.3 versus 3 for the control. Our results suggest that GSH depletion by either BSO or DEM sensitizes aerobic cells to radiation but does not appreciably alter the OER.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6647769

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  8 in total

1.  Dehydroascorbic acid uptake in a human keratinocyte cell line (HaCaT) is glutathione-independent.

Authors:  I Savini; S Duflot; L Avigliano
Journal:  Biochem J       Date:  2000-02-01       Impact factor: 3.857

Review 2.  The role of glutathione in radiation and drug induced cytotoxicity.

Authors:  J B Mitchell; A Russo
Journal:  Br J Cancer Suppl       Date:  1987-06

3.  Human esophageal cancer is distinguished from adjacent esophageal tissue by tissue cysteine concentrations.

Authors:  S M Evans; R Lew; M L Kochman; E P Wileyto; E Baum; K M Safford; C J Koch
Journal:  Dig Dis Sci       Date:  2002-12       Impact factor: 3.199

4.  Effect of cellular glutathione depletion on cadmium-induced cytotoxicity in human lung carcinoma cells.

Authors:  Y J Kang; M D Enger
Journal:  Cell Biol Toxicol       Date:  1987-12       Impact factor: 6.691

5.  Murine and human myogenic cells identified by elevated aldehyde dehydrogenase activity: implications for muscle regeneration and repair.

Authors:  Joseph B Vella; Seth D Thompson; Mark J Bucsek; Minjung Song; Johnny Huard
Journal:  PLoS One       Date:  2011-12-15       Impact factor: 3.240

6.  Glutathione and related enzyme activity in human lung cancer cell lines.

Authors:  J Carmichael; J B Mitchell; N Friedman; A F Gazdar; A Russo
Journal:  Br J Cancer       Date:  1988-10       Impact factor: 7.640

7.  Neuroserpin polymers cause oxidative stress in a neuronal model of the dementia FENIB.

Authors:  Noemi A Guadagno; Claudia Moriconi; Valerio Licursi; Emanuela D'Acunto; Paola S Nisi; Nicoletta Carucci; Antonella De Jaco; Emanuele Cacci; Rodolfo Negri; Giuseppe Lupo; Elena Miranda
Journal:  Neurobiol Dis       Date:  2017-03-28       Impact factor: 5.996

8.  Tissue Metabolic Changes Drive Cytokine Responses to Mycobacterium tuberculosis.

Authors:  Ekta Lachmandas; Ana B Rios-Miguel; Valerie A C M Koeken; Eva van der Pasch; Vinod Kumar; Vasiliki Matzaraki; Yang Li; Marije Oosting; Leo A B Joosten; Richard A Notebaart; Mahdad Noursadeghi; Mihai G Netea; Reinout van Crevel; Gabriele Pollara
Journal:  J Infect Dis       Date:  2018-06-05       Impact factor: 5.226

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.